Loading…

Loading grant details…

Active HORIZON European Commission

A drug screen for enhancers of adult neurogenesis in ageing: Drosophila as a new translationally-relevant platform


Funder European Commission
Recipient Organization Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts
Country Germany
Start Date Sep 01, 2023
End Date Feb 28, 2026
Duration 911 days
Number of Grantees 5
Roles Associated Partner; Coordinator
Data Source European Commission
Grant ID 101107384
Grant Description

Ensuring a healthy lifespan in an increasingly ageing society represents a priority and a challenge for research and innovation.

Particularly, irreversible neurodegenerative conditions are becoming hallmarks in the elderly, imposing a severe socioeconomic burden and ultimately threatening quality of life. Promoting adult neurogenesis has the potential to rejuvenate neural circuits restoring cognitive functions.

High-throughput models of adult neurogenesis can expedite the identification of mechanisms and compounds for the development of neuro-regenerative therapies.

I have evidence for physiologic and drug-induced adult neurogenesis in the genetically conserved and highly tractable model Drosophila melanogaster.

Here, I aim to i) characterize adult neurogenesis across Drosophilas lifespan; ii) identify drugs promoting neurogenesis in ageing in vivo, using the Drosophila olfactory circuit as an experimental platform; iii) test primary drug hits for their potential to promote neurogenesis on hiPSC-NSC in vitro (Host: UGOE, DE; Secondments: MPI-CE, DE; Weizmann, IL; DZNE, DE).

Next, during a Non-academic placement in a translational drug discovery company, I aim to profile prioritized hits promoting neuronal regeneration (LDC, DE). My unique background in chemical engineering and biosciences will be pivotal to successfully complete this project.

By leveraging state-of-the-art tools and support from experts in the field, Droscreeneuro represents an innovative, ambitious, and translationally-relevant approach towards the development of regenerative therapies aimed at counteracting age-related neurodegenerative diseases. Dissemination of results between specialized and general audiences will make science open to all.

Ultimately, exposure to high-quality training in the academic and non-academic sectors will substantially enhance my skills and career perspectives, to conduct research in academia and industry to promote society's wellbeing.

All Grantees

Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev; Weizmann Institute of Science; Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts; Lead Discovery Center Gmbh; Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant